tVNS During Motor Training in Older Adults

NCT ID: NCT06323954

Last Updated: 2025-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-27

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to learn about the effect of applying transcutaneous vagus nerve stimulation (tVNS) during motor training on motor learning in older adults. The main question it aims to answer is whether applying tVNS after successful motor trials (post-success tVNS) will facilitate the rate of motor learning. Participants will be randomly assigned to tVNS or sham group and receive tVNS or sham, respectively, at the outer ear during finger control training sessions. Finger control performance will be tested before and after the training sessions without outer ear stimulation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The participants will be randomly assigned to a tVNS or control group. They will visit the lab for four sessions. The main motor task is to trace target trajectories with finger forces. As the pre- and post-tests, all participants will be tested on a force tracing motor task with the left hand. There will be no electrical stimulation during the tests. During the training sessions, all participants will wear surface electrodes on the outer ear. The attachment sites are the tragus or cymba concha (depending on the shape and size of the ear) for the tVNS group and the earlobe for the sham group. The participants will perform finger training to trace target trajectories with their left finger forces. Participants in the tVNS and sham group will receive tVNS and sham stimulation, respectively, after successful finger trials.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Older Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tVNS stimulation

Brief electrical current will be applied to the vagus nerve area (the tragus or cymba concha, depending on the shape and size of the ear) immediately after successful trials during finger control training.

Group Type EXPERIMENTAL

tVNS stimulation

Intervention Type PROCEDURE

Electrical stimulation to the vagus nerve area.

Sham stimulation

Brief electrical current will be applied to the non-vagus nerve area (the earlobe) immediately after successful trials during finger control training.

Group Type SHAM_COMPARATOR

Sham stimulation

Intervention Type PROCEDURE

Electrical stimulation to the non-vagus nerve area.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tVNS stimulation

Electrical stimulation to the vagus nerve area.

Intervention Type PROCEDURE

Sham stimulation

Electrical stimulation to the non-vagus nerve area.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 65-84 years old across all races, genders, and ethnicities.
* Right-handed
* Physically and cognitively healthy

Exclusion Criteria

* Younger than 65 years old or older than 84 years old
* Current or history of cardiac disease
* Have an implanted device such as a neurostimulator or cochlear implant
* Current or history of tympanic membrane perforation
* Have a musculoskeletal issue that prevents hand function (e.g., arthritis)
* Have a vision problem not corrected by glasses or contact lenses
* Uncorrected auditory impairments
* Had a stroke or lesion (including tumor) in the brain
* Had a head injury or brain surgery
* Suffer from frequent or severe headaches
* Had a fainting spell or syncope
* Have any metal in the head such as shrapnel, surgical clips, or fragments from welding or metal work
* Have any implanted device such as cardiac pacemakers, medical pumps, or intracardiac lines
* Had any brain-related conditions (i.e. multiple sclerosis, Parkinson, Alzheimer)
* Had any illness that caused brain injury (i.e. meningitis, aneurysm, brain tumor)
* Had any head trauma that was associated with a loss of consciousness or diagnosed as a concussion
* Being treated for any psychiatric condition (i.e. depression, anxiety, PTSD, schizophrenia)
* Suspected of pregnancy
* Pregnant
* Cognitive status issues as confirmed with the Mini-Mental State Exam (MMSE \<26)
* Musculoskeletal condition or injury that would limit hand range of motion
Minimum Eligible Age

65 Years

Maximum Eligible Age

84 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Florida

OTHER

Sponsor Role collaborator

Georgia Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Minoru Shinohara, PhD

Role: PRINCIPAL_INVESTIGATOR

Georgia Institute of Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Human Neuromuscular Physiology Lab

Atlanta, Georgia, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Minoru Shinohara, PhD

Role: CONTACT

4048941030

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Minoru Shinohara, Ph.D.

Role: primary

404-894-1030

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H24110

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.